A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?
Abstract Aims Circulating biomarkers can provide important information for the diagnosis and prognosis of dilated cardiomyopathy (DCM). We explored novel biomarkers for the diagnosis and prognosis of DCM to improve clinical decision‐making. Methods and results A total of 238 DCM patients and 65 cont...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2024-02-01
|
| סדרה: | ESC Heart Failure |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/ehf2.14605 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|